Inspired by the successful television series, the UCL School of Pharmacy has organised this clever and well-attended event where UCL scientists presented their small molecule therapeutics idea to a panel of seasoned pharma experts and investors, in front of a public of scientists and company representatives. We couldn’t resist the temptation to pitch our Virology Research Services, and although VRS is not quite a small molecule, it was clearly exciting enough to win the third prize from the public! Thank you!
Recents Posts
Current and Future Antiviral Research
A virus mutates, an antiviral loses potency, and a new outbreak finds us one step behind. This cycle has defined antiviral medicine for decades. Now, a convergence of broad-spectrum drug design, host-targeted therapies, AI-driven discovery, nanotechnology, and CRISPR...
VRS Successfully Maintains ISO 9001 Certification
Virology Research Services is pleased to announce that we have successfully maintained our ISO 9001:2015 certification following our latest annual audit. This recertification confirms the continued strength and effectiveness of our Quality Management System (QMS). In...
New to Our Assay Portfolio: Human Metapneumovirus (hMPV)
VRS now offers validated antiviral and neutralisation assay services for Human Metapneumovirus (hMPV). hMPV is a leading cause of acute respiratory tract infections worldwide, particularly in young children, the elderly, and immunocompromised individuals. Despite its...
When it comes to viruses, we know our stuff!
Subscribe

